{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:23:58Z","timestamp":1792272238017,"version":"4.4.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004042","name":"KISTEC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018456","name":"Kanagawa Institute of Industrial Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005072","name":"Japanese Circulation Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23bm1123010"],"award-info":[{"award-number":["23bm1123010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.yjmcc.2023.12.001","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T10:36:07Z","timestamp":1707215767000},"page":"90-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Pluripotent stem cell-based cardiac regenerative therapy for heart failure"],"prefix":"10.1016","volume":"187","author":[{"given":"Yusuke","family":"Soma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuika","family":"Morita-Umei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Kishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shugo","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.001_bb0005","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.yjmcc.2023.12.001_bb0010","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/jamacardio.2020.2795","article-title":"Survival on the heart transplant waiting list","volume":"5","author":"Bakhtiyar","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0015","first-page":"239","article-title":"The registry report of Japanese heart Transplantation-2020","volume":"57","author":"The Japanese Society for Heart Transplantation","year":"2020","journal-title":"Ishoku."},{"issue":"5391","key":"10.1016\/j.yjmcc.2023.12.001_bb0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.001_bb0025","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.001_bb0030","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1073\/pnas.0935626100","article-title":"A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis","volume":"100","author":"Nakamura","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.001_bb0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/dbio.1998.9094","article-title":"Regulation of avian cardiac myogenesis by activin\/TGFbeta and bone morphogenetic proteins","volume":"204","author":"Ladd","year":"1998","journal-title":"Dev. Biol."},{"issue":"52","key":"10.1016\/j.yjmcc.2023.12.001_bb0040","doi-asserted-by":"crossref","first-page":"19812","DOI":"10.1073\/pnas.0605768103","article-title":"Developmental stage-specific biphasic roles of Wnt\/beta-catenin signaling in cardiomyogenesis and hematopoiesis","volume":"103","author":"Naito","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.yjmcc.2023.12.001_bb0045","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1073\/pnas.0702859104","article-title":"Biphasic role for Wnt\/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells","volume":"104","author":"Ueno","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.001_bb0050","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"27","key":"10.1016\/j.yjmcc.2023.12.001_bb0055","doi-asserted-by":"crossref","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","article-title":"Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling","volume":"109","author":"Lian","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.001_bb0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.scr.2009.02.002","article-title":"Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies","volume":"2","author":"Hentze","year":"2009","journal-title":"Stem Cell Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.001_bb0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.chembiol.2017.04.010","article-title":"Efficient, selective removal of human pluripotent stem cells via Ecto-alkaline phosphatase-mediated aggregation of synthetic peptides","volume":"24","author":"Kuang","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.001_bb0070","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.stemcr.2015.02.016","article-title":"Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein","volume":"4","author":"Tateno","year":"2015","journal-title":"Stem Cell Rep."},{"issue":"35","key":"10.1016\/j.yjmcc.2023.12.001_bb0075","doi-asserted-by":"crossref","first-page":"E3281","DOI":"10.1073\/pnas.1303669110","article-title":"Inhibition of pluripotent stem cell-derived teratoma formation by small molecules","volume":"110","author":"Lee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.001_bb0080","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cmet.2014.03.017","article-title":"Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells","volume":"19","author":"Shiraki","year":"2014","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Tohyama","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.001_bb0090","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cmet.2016.03.001","article-title":"Glutamine oxidation is indispensable for survival of human pluripotent stem cells","volume":"23","author":"Tohyama","year":"2016","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.001_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.stem.2012.11.015","article-title":"Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen","volume":"12","author":"Ben-David","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101535","article-title":"Fatty acid synthesis is indispensable for survival of human pluripotent stem cells","volume":"23","author":"Tanosaki","year":"2020","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.001_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101360","article-title":"Purification of cardiomyocytes and neurons derived from human pluripotent stem cells by inhibition of de novo fatty acid synthesis","volume":"3","author":"Tanosaki","year":"2022","journal-title":"STAR Protoc."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.001_bb0110","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jacc.2006.02.002","article-title":"Regeneration gaps: observations on stem cells and cardiac repair","volume":"47","author":"Murry","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.RES.67.1.23","article-title":"Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats","volume":"67","author":"Olivetti","year":"1990","journal-title":"Circ. Res."},{"issue":"3 Suppl","key":"10.1016\/j.yjmcc.2023.12.001_bb0120","first-page":"I141","article-title":"The relationship of myocardial infarct size and prognosis","volume":"53","author":"Caulfield","year":"1976","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.001_bb0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.scr.2015.08.002","article-title":"Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells","volume":"15","author":"Chen","year":"2015","journal-title":"Stem Cell Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.001_bb0130","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.stemcr.2014.09.017","article-title":"Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture","volume":"3","author":"Kempf","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.12.001_bb0135","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.5966\/sctm.2014-0275","article-title":"A universal and robust integrated platform for the scalable production of human cardiomyocytes from pluripotent stem cells","volume":"4","author":"Fonoudi","year":"2015","journal-title":"Stem Cells Transl. Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.001_bb0140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.stemcr.2019.06.004","article-title":"Continuous WNT control enables advanced hPSC cardiac processing and prognostic surface marker identification in chemically defined suspension culture","volume":"13","author":"Halloin","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.12.001_bb0145","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.5966\/sctm.2014-0072","article-title":"A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes","volume":"3","author":"Hemmi","year":"2014","journal-title":"Stem Cells Transl. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.001_bb0150","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.stemcr.2017.08.025","article-title":"Efficient large-scale 2D culture system for human induced pluripotent stem cells and differentiated cardiomyocytes","volume":"9","author":"Tohyama","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.001_bb0155","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/stem.1964","article-title":"Universal cardiac induction of human pluripotent stem cells in two and three-dimensional formats: implications for in vitro maturation","volume":"33","author":"Zhang","year":"2015","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0160","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1038\/s41598-019-45047-9","article-title":"Transcriptomic analysis of 3D cardiac differentiation of human induced pluripotent stem cells reveals faster cardiomyocyte maturation compared to 2D culture","volume":"9","author":"Branco","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0165","doi-asserted-by":"crossref","first-page":"10646","DOI":"10.1038\/s41598-019-47123-6","article-title":"Automation of human pluripotent stem cell differentiation toward retinal pigment epithelial cells for large-scale productions","volume":"9","author":"Regent","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0170","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77007","article-title":"Robotic search for optimal cell culture in regenerative medicine","volume":"11","author":"Kanda","year":"2022","journal-title":"Elife"},{"issue":"7504","key":"10.1016\/j.yjmcc.2023.12.001_bb0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","article-title":"Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts","volume":"510","author":"Chong","year":"2014","journal-title":"Nature"},{"issue":"7415","key":"10.1016\/j.yjmcc.2023.12.001_bb0180","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature11317","article-title":"Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts","volume":"489","author":"Shiba","year":"2012","journal-title":"Nature"},{"issue":"7625","key":"10.1016\/j.yjmcc.2023.12.001_bb0185","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature19815","article-title":"Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts","volume":"538","author":"Shiba","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.001_bb0190","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt.4162","article-title":"Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates","volume":"36","author":"Liu","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.001_bb0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jacbts.2020.11.017","article-title":"Intramyocardial transplantation of human iPS cell-derived cardiac spheroids improves cardiac function in heart failure animals","volume":"6","author":"Kawaguchi","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.001_bb0200","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","article-title":"Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular Tachyarrhythmias","volume":"12","author":"Romagnuolo","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.001_bb0205","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.celrep.2016.12.040","article-title":"Neonatal transplantation confers maturation of PSC-derived cardiomyocytes conducive to modeling cardiomyopathy","volume":"18","author":"Cho","year":"2017","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.001_bb0210","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.stemcr.2016.10.009","article-title":"In vivo maturation of human induced pluripotent stem cell-derived cardiomyocytes in neonatal and adult rat hearts","volume":"8","author":"Kadota","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0215","doi-asserted-by":"crossref","first-page":"11883","DOI":"10.1038\/s41598-020-68373-9","article-title":"Increased predominance of the matured ventricular subtype in embryonic stem cell-derived cardiomyocytes in vivo","volume":"10","author":"Ichimura","year":"2020","journal-title":"Sci. Rep."},{"issue":"435","key":"10.1016\/j.yjmcc.2023.12.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5457","article-title":"Cardiac differentiation of pluripotent stem cells and implications for modeling the heart in health and disease","volume":"10","author":"Devalla","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.001_bb0225","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nmeth.2524","article-title":"Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Nunes","year":"2013","journal-title":"Nat. Methods"},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.001_bb0230","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/stem.2036","article-title":"Mechanical stress promotes maturation of human myocardium from pluripotent stem cell-derived progenitors","volume":"33","author":"Ruan","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122174","article-title":"Heart-derived collagen promotes maturation of engineered heart tissue","volume":"299","author":"Tani","year":"2023","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.yjmcc.2023.12.001_bb0240","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.celrep.2015.08.042","article-title":"Defined MicroRNAs induce aspects of maturation in mouse and human embryonic-stem-cell-derived cardiomyocytes","volume":"12","author":"Lee","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0245","doi-asserted-by":"crossref","first-page":"7648409","DOI":"10.1155\/2017\/7648409","article-title":"IGF1 and NRG1 enhance proliferation, metabolic maturity, and the force-frequency response in hESC-derived engineered cardiac tissues","volume":"2017","author":"Rupert","year":"2017","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0250","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yjmcc.2014.04.005","article-title":"Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells","volume":"72","author":"Yang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.12.001_bb0255","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.117.311920","article-title":"Thyroid and glucocorticoid hormones promote functional T-tubule development in human-induced pluripotent stem cell-derived cardiomyocytes","volume":"121","author":"Parikh","year":"2017","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.001_bb0260","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.stemcr.2019.08.013","article-title":"Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells","volume":"13","author":"Yang","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.001_bb0265","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.stem.2022.02.011","article-title":"PPARdelta activation induces metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes","volume":"29","author":"Wickramasinghe","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.001_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230001","article-title":"Practical adoption of state-of-the-art hiPSC-cardiomyocyte differentiation techniques","volume":"15","author":"Rupert","year":"2020","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.001_bb0275","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/CIRCRESAHA.116.310328","article-title":"Safe and effective cardiac regenerative therapy with human-induced pluripotent stem cells: how should we prepare pure cardiac myocytes?","volume":"120","author":"Tohyama","year":"2017","journal-title":"Circ. Res."},{"issue":"19","key":"10.1016\/j.yjmcc.2023.12.001_bb0280","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.116.024145","article-title":"Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair","volume":"135","author":"Tiburcy","year":"2017","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.yjmcc.2023.12.001_bb0285","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.120.047904","article-title":"Human engineered heart tissue patches remuscularize the injured heart in a dose-dependent manner","volume":"143","author":"Querdel","year":"2021","journal-title":"Circulation"},{"issue":"11 Suppl 1","key":"10.1016\/j.yjmcc.2023.12.001_bb0290","first-page":"S29","article-title":"Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model","volume":"126","author":"Kawamura","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.001_bb0295","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.stemcr.2016.01.012","article-title":"Cardiomyocytes derived from MHC-homozygous induced pluripotent stem cells exhibit reduced allogeneic immunogenicity in MHC-matched non-human primates","volume":"6","author":"Kawamura","year":"2016","journal-title":"Stem Cell Rep."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.12.001_bb0300","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3727\/096368914X685799","article-title":"Functional and electrical integration of induced pluripotent stem cell-derived cardiomyocytes in a myocardial infarction rat heart","volume":"24","author":"Higuchi","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0305","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1038\/srep06716","article-title":"Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration","volume":"4","author":"Masumoto","year":"2014","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.001_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201650","article-title":"Human iPS cell-derived cardiac tissue sheets for functional restoration of infarcted porcine hearts","volume":"13","author":"Ishigami","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0315","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1038\/s41598-019-46409-z","article-title":"Human iPS cell-derived engineered heart tissue does not affect ventricular arrhythmias in a guinea pig cryo-injury model","volume":"9","author":"Pecha","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.001_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131446","article-title":"Enhanced electrical integration of engineered human myocardium via Intramyocardial versus Epicardial delivery in infarcted rat hearts","volume":"10","author":"Gerbin","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.001_bb0325","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCRESAHA.115.306985","article-title":"Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model","volume":"117","author":"Riegler","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yjmcc.2022.03.013","article-title":"Transmural myocardial repair with engineered heart muscle in a rat model of heterotopic heart transplantation \u2013 a proof-of-concept study","volume":"168","author":"Jebran","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"16","key":"10.1016\/j.yjmcc.2023.12.001_bb0335","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.117.030785","article-title":"Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine","volume":"137","author":"Gao","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.001_bb0340","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/cvr\/cvad004","article-title":"Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice","volume":"119","author":"Lou","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.12.001_bb0345","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa060186","article-title":"Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction","volume":"355","author":"Sch\u00e4chinger","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"27","key":"10.1016\/j.yjmcc.2023.12.001_bb0350","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)","volume":"36","author":"Mathiasen","year":"2015","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.yjmcc.2023.12.001_bb0355","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.yjmcc.2023.12.001_bb0360","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial","volume":"307","author":"Perin","year":"2012","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.yjmcc.2023.12.001_bb0365","first-page":"648","article-title":"Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial","volume":"38","author":"Bartunek","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0370","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yjmcc.2022.11.004","article-title":"Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: inefficient procedure for cardiac regeneration","volume":"174","author":"Kobayashi","year":"2023","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.001_bb0375","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.stemcr.2021.08.005","article-title":"Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes","volume":"16","author":"Nakamura","year":"2021","journal-title":"Stem Cell Rep"},{"issue":"15","key":"10.1016\/j.yjmcc.2023.12.001_bb0380","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCULATIONAHA.122.060124","article-title":"Contractile force of transplanted cardiomyocytes actively supports heart function after injury","volume":"146","author":"St\u00fcdemann","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.001_bb0385","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1161\/CIRCRESAHA.117.310803","article-title":"Paracrine effects of the pluripotent stem cell-derived cardiac myocytes salvage the injured myocardium","volume":"121","author":"Tachibana","year":"2017","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.001_bb0390","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cardiores.2004.10.004","article-title":"Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice","volume":"65","author":"Hattan","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.001_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133308","article-title":"Gelatin hydrogel enhances the engraftment of transplanted cardiomyocytes and angiogenesis to ameliorate cardiac function after myocardial infarction","volume":"10","author":"Nakajima","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.001_bb0400","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.stemcr.2017.09.003","article-title":"Human induced pluripotent stem cell-derived cardiomyocyte encapsulating bioactive hydrogels improve rat heart function post myocardial infarction","volume":"9","author":"Chow","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"16","key":"10.1016\/j.yjmcc.2023.12.001_bb0405","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015841","article-title":"Laminin-221 enhances therapeutic effects of human-induced pluripotent stem cell-derived 3-dimensional engineered cardiac tissue transplantation in a rat ischemic cardiomyopathy model","volume":"9","author":"Samura","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.12.001_bb0410","first-page":"4415","article-title":"Engineering hiPSC-CM and hiPSC-EC laden 3D nanofibrous splenic hydrogel for improving cardiac function through revascularization and remuscularization in infarcted heart","volume":"6","author":"Guan","year":"2021","journal-title":"Bioact. Mater."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.001_bb0415","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.healun.2018.11.002","article-title":"Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell\u2013derived cardiomyocytes","volume":"38","author":"Tabei","year":"2019","journal-title":"J. Heart Lung Transplant."},{"issue":"16","key":"10.1016\/j.yjmcc.2023.12.001_bb0420","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.biomaterials.2013.02.022","article-title":"The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction","volume":"34","author":"Moon","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0425","article-title":"Co-transplantation of mesenchymal stromal cells and induced pluripotent stem cell-derived cardiomyocytes improves cardiac function after myocardial damage","volume":"8","author":"Neef","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0430","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1038\/s41598-020-58126-z","article-title":"Syngeneic mesenchymal stem cells reduce immune rejection after induced pluripotent stem cell-derived allogeneic cardiomyocyte transplantation","volume":"10","author":"Yoshida","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.12.001_bb0435","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41587-019-0197-9","article-title":"Epicardial cells derived from human embryonic stem cells augment cardiomyocyte-driven heart regeneration","volume":"37","author":"Bargehr","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.001_bb0440","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCULATIONAHA.120.049497","article-title":"Cyclin D2 overexpression enhances the efficacy of human induced pluripotent stem cell-derived cardiomyocytes for myocardial repair in a swine model of myocardial infarction","volume":"144","author":"Zhao","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.yjmcc.2023.12.001_bb0445","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jacbts.2016.07.006","article-title":"Translation of cardiac myosin activation with 2-deoxy-ATP to treat heart failure via an experimental ribonucleotide reductase-based gene therapy","volume":"1","author":"Thomson","year":"2016","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0450","article-title":"Cell based dATP delivery as a therapy for chronic heart failure","author":"Mhatre","year":"2023","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0455","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1038\/s41467-021-23329-z","article-title":"Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells","volume":"12","author":"Funakoshi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0460","first-page":"286","article-title":"Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse","volume":"20","author":"Wu","year":"2023","journal-title":"Bioact. Mater."},{"issue":"18","key":"10.1016\/j.yjmcc.2023.12.001_bb0465","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/CIRCULATIONAHA.121.053563","article-title":"In vitro matured human pluripotent stem cell-derived cardiomyocytes form grafts with enhanced structure and function in injured hearts","volume":"145","author":"Dhahri","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.001_bb0470","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.yjmcc.2010.09.008","article-title":"Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats","volume":"49","author":"Fernandes","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.001_bb0475","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1074248413520344","article-title":"Electrical integration of human embryonic stem cell-derived cardiomyocytes in a Guinea pig chronic infarct model","volume":"19","author":"Shiba","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2022.01.007","article-title":"Human engineered heart tissue transplantation in a guinea pig chronic injury model","volume":"166","author":"von Bibra","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.001_bb0485","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.stem.2023.03.010","article-title":"Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy","volume":"30","author":"Marchiano","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.001_bb0490","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.7150\/thno.22980","article-title":"The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction","volume":"8","author":"Neyrinck","year":"2018","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.001_bb0495","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/sctm.20-0019","article-title":"CRISPR\/Cas9-mediated introduction of the sodium\/iodide symporter gene enables noninvasive invivo tracking of induced pluripotent stem cell-derived cardiomyocytes","volume":"9","author":"Ostrominski","year":"2020","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0500","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.medj.2022.10.003","article-title":"A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population","volume":"4","author":"Yoshida","year":"2023","journal-title":"Med"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.001_bb0505","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.111.249243","article-title":"Immunogenicity of pluripotent stem cells and their derivatives","volume":"112","author":"de Almeida","year":"2013","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.12.001_bb0510","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s12015-013-9457-0","article-title":"Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin","volume":"9","author":"Lu","year":"2013","journal-title":"Stem Cell Rev. Rep."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.001_bb0515","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.12.001_bb0520","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.12.001_bb0525","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/TP.0000000000000875","article-title":"New immunosuppressive cell therapy to prolong survival of induced pluripotent stem cell-derived allografts","volume":"99","author":"Sasaki","year":"2015","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0530","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41598-019-57088-1","article-title":"Efficient generation of thymic epithelium from induced pluripotent stem cells that prolongs allograft survival","volume":"10","author":"Otsuka","year":"2020","journal-title":"Sci. Rep."},{"issue":"30","key":"10.1016\/j.yjmcc.2023.12.001_bb0535","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","article-title":"Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report","volume":"36","author":"Menasch\u00e9","year":"2015","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.12.001_bb0540","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","article-title":"Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction","volume":"71","author":"Menasch\u00e9","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0545","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yjmcc.2023.08.002","article-title":"Human PSC-derived cardiac cells and their products: therapies for cardiac repair","volume":"183","author":"Menasch\u00e9","year":"2023","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0550","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.950829","article-title":"Case report: transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy","volume":"9","author":"Miyagawa","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0555","unstructured":"Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure (BioVAT-HF). Identifier: NCT04396899."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.001_bb0560","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/d41591-023-00027-5","article-title":"Stem cell-derived heart cells injected into first patient","volume":"29","author":"Carvalho","year":"2023","journal-title":"Nat. Med."},{"issue":"7808","key":"10.1016\/j.yjmcc.2023.12.001_bb0565","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/d41586-020-01285-w","article-title":"Revealed: two men in China were first to receive pioneering stem-cell treatment for heart disease","volume":"581","author":"Mallapaty","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.12.001_bb0570","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-056264","article-title":"Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I\/IIa dose-escalation clinical trial","volume":"12","author":"Zhang","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0575","unstructured":"Treating Congestive HF With HiPSC-CMs Through Endocardial Injection. Identifier: NCT04982081."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0580","unstructured":"Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy For Chronic Ischemic Left Ventricular Dysfunction (HECTOR). Identifier: NCT05068674."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.12.001_bb0585","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.stemcr.2023.08.011","article-title":"Seamless and non-destructive monitoring of extracellular microRNAs during cardiac differentiation from human pluripotent stem cells","volume":"18","author":"Sekine","year":"2023","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0590","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.stemcr.2014.11.004","article-title":"SHOX2 overexpression favors differentiation of embryonic stem cells into cardiac pacemaker cells, improving biological pacing ability","volume":"4","author":"Ionta","year":"2015","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.12.001_bb0595","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/jcp.27018","article-title":"TBX18 transcription factor overexpression in human-induced pluripotent stem cells increases their differentiation into pacemaker-like cells","volume":"234","author":"Gorabi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yjmcc.2023.12.001_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110612","article-title":"Overexpression of TBX3 in human induced pluripotent stem cells (hiPSCs) increases their differentiation into cardiac pacemaker-like cells","volume":"130","author":"Zhao","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.12.001_bb0605","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nbt.3745","article-title":"Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker","volume":"35","author":"Protze","year":"2017","journal-title":"Nat. Biotechnol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:22:49Z","timestamp":1777418569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282823001955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":121,"alternative-id":["S0022282823001955"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.12.001","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pluripotent stem cell-based cardiac regenerative therapy for heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}